Just in Time GCP Named Among Top Women-Owned Businesses & Inc. 5000

Just in Time GCP Named Among Top Women-Owned Businesses & Inc. 5000

Just in Time GCP, a women-owned clinical research company specializing in GCP compliance, is proud to announce dual recognition in 2024:

  • Ranked #9 on the Philadelphia Business Journal’s list of the Largest Women-Owned Businesses in Greater Philadelphia.

  • Named to the Inc. 5000 list of America’s Fastest Growing Private Companies—for the fourth consecutive year.

These honors reflect both our sustained business growth and our role as a women-owned clinical research company committed to excellence, diversity, and innovation.

Why These Recognitions Matter

In clinical research, recognition is not just about company size or revenue—it’s about impact. For Just in Time GCP, these achievements highlight:

  • Commitment to Clinical Quality: We partner with sponsors to ensure GCP inspection readiness, TMF quality, and clinical operational excellence.

  • Sustained Growth and Innovation: Earning a place on the Inc. 5000 four years in a row shows the value of our forward-looking approach to risk-based oversight, eClinical systems, and AI-enabled TMF solutions.

  • Championing Diversity: Being among the largest women-owned businesses in Philadelphia reflects our commitment to diversity, equity, and inclusion across the clinical research industry.

  • Trusted Partner to Sponsors: With over 20 years of experience, 400+ successful projects, and a 95% repeat/referral rate, our recognition reinforces the trust our clients place in us.

Growth Fueled by Purpose

Just in Time GCP’s inclusion in the Inc. 5000 four years running underscores the growing demand for trusted clinical partners. Sponsors are seeking support to:

  • Maintain contemporaneous TMFs across global studies.

  • Implement risk-based oversight to align with regulatory expectations.

  • Strengthen data integrity and inspection readiness through proactive strategies.

Our purpose has always been clear: simplify clinical compliance, reduce risks, and enable sponsors to deliver therapies to patients with confidence.

A High-Energy, Purpose-Driven Team

Behind every recognition is the people who made it possible. Our remote-first model empowers a diverse, talented team to thrive in a collaborative environment while delivering measurable results for our clients. Passion, accountability, and commitment to quality are the cornerstones of our culture.

Looking Ahead

As we celebrate these recognitions, we remain focused on our mission: helping sponsors meet the demands of ICH E6(R3), strengthen their TMF processes, and achieve lasting inspection-ready confidence.